Dupilumab treatment normalizes skin barrier function and improves patient-reported outcomes in patients aged 6 to 11 years with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Cork, M. J. [1 ,2 ]
Leung, D. Y. M. [3 ]
Ong, P. [4 ]
Danby, S. G. [1 ]
Ramirez-Gama, M. [3 ]
Garcia, S. [3 ]
Taylor, P. [3 ]
Zahn, J. [5 ]
Praestgaard, A. [6 ]
Bologna, G. [6 ]
Zhang, A. [6 ]
机构：
[1] Univ Sheffield, Sheffield Dermatol Res, Sheffield, England
[2] Sheffield Childrens Hosp, Sheffield, England
[3] Natl Jewish Hlth, Denver, CO USA
[4] Univ Southern Calif, Childrens Hosp Los Angeles, Los Angeles, CA USA
[5] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[6] Sanofi, Cambridge, MA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
55
引用
收藏
页码：S342 / S342
页数：1
相关论文
共 50 条
  • [41] 411 Long term laboratory safety of dupilumab in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis
    Siegfried, Elaine
    Cork, Michael J.
    Lockshin, Benjamin
    Boguniewicz, Mark
    Uppal, Sumeet
    Khokhar, Faisal A.
    Bansal, Ashish
    Sierka, Debra
    Cyr, Sonya
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [42] Long Term Hematologic Laboratory Safety of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
    Siegfried, Elaine
    Cork, Michael J.
    Lockshin, Benjamin
    Boguniewicz, Mark
    Uppal, Sumeet
    Vass, Maria
    Khokhar, Faisal A.
    Bansal, Ashish
    Sierka, Debra
    Cyr, Sonya
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB62 - AB62
  • [43] Blockade of interleukin-13 signalling improves skin barrier function and biology in patients with moderate-to-severe atopic dermatitis
    Sander, Nicole
    Stoelzl, Dora
    Fonfara, Melina
    Hartmann, Jan
    Harder, Inken
    Suhrkamp, Ina
    Jakasa, Ivone
    van den Bogaard, Ellen
    van Vlijmen-Willems, Ivonne
    Szymczak, Silke
    Rodriguez, Elke
    Gerdes, Sascha
    Weidinger, Stephan
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (03) : 344 - 350
  • [44] Lebrikizumab Combined with Topical Corticosteroids Improves Patient- reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis
    Tanaka, Akio
    Igawa, Ken
    Takahashi, Hidetoshi
    Shimizu, Ryosuke
    Kataoka, Yoko
    Torisu-Itakura, Hitoe
    Morisaki, Yoji
    Montmayeur, Sonia
    Katoh, Norito
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [45] Dupilumab provides improvement in sleep in children aged ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, A.
    Wollenberg, A.
    Simpson, E.
    Beck, L.
    Hong, C-H
    Marcoux, D.
    Chen, Z.
    Levit, N.
    Bansal, A.
    Rossi, A.
    Chao, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 57 - 58
  • [46] Patient-reported outcomes for patients with black skin and atopic dermatitis
    不详
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (04) : 665 - 665
  • [47] Dupilumab treatment improved sleep quality in moderate-to-severe atopic dermatitis in children aged 6 months-5 years and their caregivers
    Paller, Amy S.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Cork, Michael J.
    Wollenberg, Andreas
    Arkwright, Peter D.
    Zhang, Haixin
    Wang, Zhixiao
    Marco, Ainara R.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E112 - E113
  • [48] Short Course Of Oral Prednisolone Improves Physician Reported Clinical Scores and Patient Reported Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis
    Price, Emma
    Krisna, Sai Sakktee
    Howie, Karen J.
    Brar, Rashie
    Alasgah, Eman
    Munoz, Caroline
    O'Byrne, Paul M.
    Sehmi, Roma
    Gauvreau, Gail M.
    Lima, Hermenio
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB134 - AB134
  • [49] LEBRIKIZUMAB IMPROVES CLINICAL MANIFESTATIONS AND PATIENT-REPORTED OUTCOMES IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: PHASE 2B STUDY RESULTS
    Ali, Z.
    Guttman-Yassky, E.
    Blauvelt, A.
    Eichenfield, L.
    Paller, A.
    Armstrong, A.
    Drew, J.
    Gopalan, R.
    Simpson, E.
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 32 - 32
  • [50] Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis
    Ferrucci, Silvia
    Romagnuolo, Maurizio
    Maronese, Carlo Alberto
    Germiniasi, Francesca
    Tavecchio, Simona
    Angileri, Luisa
    Casazza, Giovanni
    Marzano, Angelo Valerio
    Genovese, Giovanni
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
12345